The nutritional status of patients supplemented with Renilon 7.5 for 3 months will be improved compared with patients who receive the standard treatment. Nutritional status will be assessed by a significant improvement after 3 months of treatment by…
ID
Bron
Verkorte titel
Aandoening
End stage renal disease patients on hemodialysis.
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Nutritional status as assessed by nPCR, serum albumin, serum pre-albumin, serum creatinine, and dry body weight.
Achtergrond van het onderzoek
Renilon 7.5 was developed to provide HD patients with adequate energy and protein with very low amounts of minerals. HD patients with a low protein intake were randomized in this controlled parallel design study to use the test product for an intervention period of 3 months. Nutritional status, phosphate binder use, Quality of Life, dietary intake and blood parameters were evaluated at regular intervals throughout the intervention period.
Doel van het onderzoek
The nutritional status of patients supplemented with Renilon 7.5 for 3 months will be improved compared with patients who receive the standard treatment. Nutritional status will be assessed by a significant improvement after 3 months of treatment by the following parameters: nPCR, serum albumin, serum pre-albumin, serum creatinine or dry-body weight.
Onderzoeksopzet
N/A
Onderzoeksproduct en/of interventie
Duration intervention: 3 Months.
Intervention group: Standard therapy and additionally daily a nutritional energy dense (2kcal/ml) supplement containing 7.5 g/100ml of demineralised whey protein and very low amounts of minerals (especially phosphate) which provides 500 kcal of energy and 18.8 gram protein.
Control group: all subjects in the control group received standard therapy.
Publiek
PO Box 7005
Jane McKenzie
Wageningen 6700 CA
The Netherlands
+31 (0)317 467800
Jane.McKenzie@Numico-Research.nl
Wetenschappelijk
PO Box 7005
Jane McKenzie
Wageningen 6700 CA
The Netherlands
+31 (0)317 467800
Jane.McKenzie@Numico-Research.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
End-stage renal disease patients on hemodialysis treatment:
1. requiring thrice weekly hemodialysis for at least 3 months;
2. stable disease (no recent hospitalizations except for minor access-related stays);
3. C-reactive protein<20 mg/L;
4. nPCR<1.0;
5. informed consent.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Inadequate dialysis (Kt/V < 1.2);
2. peritoneal dialysis in the last three months;
3. serum albumin > 40 g/L;
4. BMI > 30 kg/m2;
5. use of any investigational drug;
6. nutritional supplementation within the last two months;
7. requiring complete enteral nutrition;
8. age < 18 years.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL638 |
| NTR-old | NTR698 |
| Ander register | : Protocol Number 100059 |
| ISRCTN | ISRCTN56882109 |